Internal Medicine Alert - March 30, 2007

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of Califronia, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York

Associate Editors
Joseph Varon, MD, FACP, FCCP, FCCM
Professor
University of Texas Health Science Center;
St. Luke's Episcopal Hospital
Houston

Barbara A. Phillips, MD, MSPH
Professor of Medicine
University of Kentucky;
Director
Sleep Disorders Center
Samaritan Hospital
Lexington

Malcolm Robinson, MD, FACP, FACG
Emeritus Clinical Professor of Medicine
University of Oklahoma College of Medicine
Oklahoma City

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine University of California
San Francisco

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Author
William B. Ershler, MD
INOVA Fairfax Hospital Cancer Center
Fairfax, VA;
Director
Institute for Advanced Studies in Aging
Washington, DC

Subjects:

  • Analgesics and the Risk of Hypertension
  • Do Naps Get a Bad Rap?
  • Fecal Blood Testing for Colorectal Neoplasia
  • Having Sons Reduces the Risk of Prostate Cancer
  • Mesalamine Delayed Release Tablets (Lialda)
  • Clinical Briefs by Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens
  • Describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Abbott, Amylin, Boehringer Ingelheim, Novo Nordisk, Eli Lilly, Endo. Peer reviewer Gerald Roberts, MD, associate editors Joseph Varon, MD, FACP, FCCP, FCCM, Barbara A. Phillips, MD, MSPH, Malcolm Robinson, MD, FACP, FACG, James Chan, PharmD, PhD, William T. Elliott, MD, FACP, and author William B. Ershler, MD report no financial relationships to this field of study. Associate editor Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2007 AHC Media. All rights reserved.